Company intelligence / Profile preview

SpectronRx

Fishers, Indiana, United Statesspectronrx.com ↗

Ownership: Private
Employees: ~20
Development stage: Commercial

Overview

SpectronRx provides end-to-end CDMO services specializing in radiopharmaceuticals from early-stage development to commercial manufacturing. The company has supported the approval of drugs such as FDG, NaF, and Ammonia. It offers advanced expertise in monoclonal antibody labeling with a wide range of isotopes including Ac-225, Pb-212, Lu‑177, I‑123/131 among others.

Therapeutic areas: Other
Modalities: RadiopharmaceuticalMonoclonal antibodyNanobody therapyPeptides
Industry: Contract Manufacturing Organization

Partnerships

Arizona Isotopes (collaboration on Bunker Hill cyclotron facility)

Beyond the preview

Go deeper on SpectronRx.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on SpectronRx.

Explore the full profile